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We studied the effect of tobacco smoking on macrophage lipid index and macrophage smokers
inclusions in induced sputum in 256 patients (143 non-smokers, 81 ex-smokers and 32 current
smokers). Lipid index was, using the Oil red O stain, the sum of the lipid staining droplet score
(range 0e4) in 100 macrophages. Smokers inclusions were assessed using Wright’s stain and
graded as “none”, “few”, “moderate” or “many”. Lipid index was significantly higher in
current smokers (112.5, SD 58.5 units) than ex-smokers (29.2, SD 42.8 units) or non-smokers
(13.4, SD 121.7). Smokers inclusions were present in all current smokers but only in 2 non-
smokers. The mean smoking history of current smokers with few macrophage inclusions was
15.0 (SD 11.2), moderate 21.6 (SD 15.7), and many 30.0 (SD 21.9) pack years. There was
a significant difference between the length of time ex-smokers had quit smoking if they had
no or few smokers inclusions (mean 17.6 (SD 11.2) years) compared to those with moderate
or many smokers inclusions (mean 2.8 (SD 5.8) years) (p Z 0.01). Lipid index was significantly
correlated with smokers inclusions (rZ 0.72, p < 0.01). We conclude that smoker’s inclusions
within sputum macrophages is a reliable indicator of cigarette smoking and that the sputum
lipid index cannot be used as an assessment of oropharyngeal reflux in cigarette smokers.
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trations (3%, 4%, and 5%) of hypertonic saline and processedGastric aspiration is commonly associated with chronic
respiratory disease2,3 but is often difficult to diagnose as no
gold standard test exists. An assessment of lipid granules in
bronchial macrophages has been used as well as other
investigations, such as dual channel 24 h pH monitoring,4
radiological techniques5 or response to therapy. Corwin
and Irwin6 developed a lipid index (LI) as a method of
quantifying the amount of lipid within macrophages in
bronchoalveolar lavage and suggested that this was useful
in the diagnosis of aspiration. Since then, other investiga-
tors have also measured the lipid index in bronchoalveolar
lavage, sputum, and tracheal washings and found it to be
a useful indicator of aspiration.7 More recently use of the
lipid index in induced sputum was validated and shown to
have high sensitivity and specificity for oropharyngeal
reflux as diagnosed by upper esophageal reflux.4
Lipid within macrophages, however, can either come
from an exogenous source, such as aspiration in healthy
non-smokers, or an endogenous source.6,8 Anecdotally, we
had noticed that the lipid index was often raised in patients
who smoked without evidence of aspiration. We, therefore,
wished to test the hypothesis that tobacco smoking would
increase the macrophage lipid index in induced sputum by
examining the relationship between smoking history and
lipid index. Tobacco smoking causes increases in the size
and number of alveolar macrophages. They contain char-
acteristic inclusion bodies within the cytoplasm as a result
of phagocctosis of smoke particulates.9 Macrophage
smoker’s inclusion (MSI) may therefore be a surrogate
marker of cigarette smoke exposure status.10 Therefore,
we also examined their relationship with the macrophage
lipid index. Since the lipid index is also influenced by
gastroesophageal reflux,4 we assessed this in a subset of
patients.Methods
339 adult subjects underwent sputum induction. Induction
was unsuccessful in 83 patients and, therefore, data were
available from 256 (164 females) patients, mean age 54.7
(SD 14.3) years. The majority of the patients had chronic
cough as their only symptom. None had evidence of fat
embolism, lipid storage disease or pulmonary alveolar
proteinosis. Clinical data were obtained at the time of
initial consultation before sputum data were available and
the staff carrying out the sputum examination was blind to
the smoking history.
The smoking history was taken in a structured way and
expressed as pack years (One pack year is an average of 20
cigarettes per day for one year). For ex-smokers the
number of years since quitting was also recorded. Where
there was doubt about the accuracy of the information, the
history was cross-checked with independent histories
obtained in the sputum induction or the esophageal motility
laboratories.
Spirometry was performed with a Koko-Trek Spirometer
(Trudell Medical, London, Ontario, Canada) according to
ATS specifications11 using standard values.12Sputum was induced by nebulising increasing concen-
within 2 h according to the method described by Pizzichini
et al.13 Cytospins were stained by Wright’s stain for
differential cell count (DCC) and macrophage smokers
inclusions (MSI). MSI appear as coarse, darkly basophilic
cytoplasmic granules (Fig. 1). A semi-quantitative assess-
ment was used: “none” no inclusions in any macrophages on
the cytospin, “few” <20% of the macrophages per field
(400) displayed inclusions, “moderate” 20e50% and
“many” >50%. Oil red O (SigmaeAldrich Canada Ltd.,
Oakville, Ontario, Canada) staining was used for detection
of macrophage cytoplasmic lipid bodies. One hundred
consecutive macrophages were evaluated according to the
method described by Corwin and Irwin6: 0 no staining, 1 one
or a few lipid droplets, 2 many distinct droplets, 3 many
droplets with visible nucleus, 4 many droplets in cytoplasm
with obscured nucleus (Fig. 1). The lipid index was the
sum of the lipid scores of 100 macrophages (range of
0e400).
Esophageal pH measurements used an ambulatory digi-
trapper (MeditronicseSynectics, Stockholm, Sweden), off
anti-reflux medications. If patients were on medications,
they were withheld for at least 5 days before the test. The
pH electrode was positioned 5 cm above the manometri-
cally determined lower esophageal sphincter and the
cumulative time recorded when pH was below 4.0. Patho-
logical gastroesophageal reflux was present if the pH was
below 4.0 for >4% of the time.
Data are expressed as mean (SD). ANOVA was used to
determine the effect of smoking status on age, spirometry,
smoking history, sputum (DCC), and LI, and the effect of MSI
on pack year smoking history and lipid index. Post hoc
testing used the Bonferroni procedure. Pearson correlation
was used to evaluate the relationship between the MSI and
smoking history or LI. Student’s unpaired t-test was used
for to compare the LI in smokers with and without gastro-
esophageal reflux. The analysis used SPSS for Windows
10.0.5. Confidence intervals on the proportion of smokers
with MSI and ex-smokers with no MSI were calculated using
the method of Gardner and Altman.14
This study is part of another study approved by the
hospital Research Ethics Board entitled “The Evaluation of
Exogenous Lipid Pneumonia in Induced Sputum”. All
patients provided written informed consent.Results
Demographic details, spirometric values, and pack year
smoking history for smokers, ex-smokers and current
smokers were examined (Table 1). Ex-smokers had quit on
average 16.3 (SD 11.7) years prior to investigation. Current
smokers were significantly younger than ex-smokers (95% CI
for difference 22.8e9.2 years) and non-smokers (17.5e4.8
years) (p < 0.05). Compared to the non-smokers, FEV1%
predicted was significantly lower in both ex-smokers (95% CI
for difference 3.2e16.2%) and current smokers (1.2e18.9%)
but this reduction was modest and not, on average, low
enough to indicate airflow obstruction. The differential cell
count data were normal (or not significantly different from
normal) (Table 2). There were no statistically significant
Figure 1 (a) lipid inclusions within sputum macrophage (b) smoker’s inclusions within sputum macrophages.
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smokers, and current smokers.
The lipid index was significantly higher in current
smokers (mean 112.5, SD 58.5) than ex-smokers (mean
29.2, SD 42.8) or non-smokers (mean 13.4, SD 121.7)
(Fig. 2). This amounted to a 99.1 units difference (95% CI for
difference 82.1e116.3) and 83.3 (65.0e101.7) difference
between smokers versus non-smokers and ex-smokers
respectively.
We examined the relationship of sputum macrophage
smokers inclusions (MSI) and smoking status, pack year
smoking history and lipid index. All current smokers had at
least a few MSI and only 2 of 143 non-smokers had evidence
of MSI (Table 3). In current smokers there was a trend to
a relationship between MSI and pack year smoking history
(r Z 0.34, p Z 0.06) (Fig. 3) which was not seen in ex-
smokers (r Z 0.10, p Z 0.40). In ex-smokers the mean
pack year smoking history of ex-smokers with none, few,
moderate or many MSI was 26.5 (SD 26.8), 38.2 (SD 26.2),
30.6 (SD 13.4), 34.4 (SD 7.5) respectively. There was also
a significant negative correlation between MSI and years
quit (r Z 0.31 p < 0.01). Furthermore, there was
a significant difference between the time since quit
smoking in ex-smokers with no or few MSI (mean of 17.6 (SD
11.2) years) versus ex-smokers with moderate or many MSI
of 2.8 (SD 5.8) years) (p Z 0.01).Table 1 Demographic details and spirometry.
Non-smoker Ex-smoker Current smoker
Number 143 81 32
Age (year) 54.6 (14.6) 59.4 (12.4) 43.4 (10.3)a
Smoking
(pack year)
0 28.0 (25.2) 23.2 (18.1)
Male (%) 70 56 59
FEV1 (l) 2.59 (0.86) 2.40 (0.94)
b 2.73 (0.87)
FEV1
(% predicted)
91.6 (15.9) 81.9 (22.2)b 81.6 (18.3)b
VC (l) 3.2 (1.01) 3.1 (1.03)b 3.48 (1.01)b
FEV1/VC (%) 81.2 (6.1) 76.8 (10.0)
b 77.9 (7.1)
Data are expressed as mean (SD).
a Significant difference compared to non-smokers and ex-
smokers.
b Significant difference compared to non-smokers.The lipid index was also significantly correlated with MSI
on a semi-quantitative scale none (16 (SD 2) units) versus
few (58 (SD 14) units), moderate (119 (SD 11) units and
many MSI (123 (SD 15) units) (r Z 0.72 p < 0.01).
Of the 18 subjects (7 smokers) who underwent 24-h pH
monitoring, 11 reached diagnostic criteria for gastro-
esophageal reflux. There was no significant difference
between the lipid index of smokers with gastroesophageal
reflux (mean of 127 (SD 48) units) or without 83 (SD 61)
units).
Discussion
The principal observations in the current study are: 1)
macrophage smokers inclusions (MSI) were closely associ-
ated with cigarette smoking and tended to decline over
time in ex-smokers, 2) the macrophage lipid index (LI) in
induced sputum was elevated in patients with a history of
either current or previous cigarette smoking, and 3) the
presence of MSI was associated with increases in LI.
The MSI appear as coarse, darkly basophilic cytoplasmic
granules. The granules are characteristic of smokers and
have been described since the 1970’s.15 MSI appear to be
a good marker for cigarette smoke exposure but we were
unable to find studies which may suggest that inclusions
could be used in a quantitative manner to assess the extent
of exposure to tobacco smoke. Previous data suggest that
the numbers of MSI remain elevated for a several years.
Agius et al.16 evaluated the number of macrophages with
MSI in the bronchoalveolar lavage of smokers, ex-smokers
and non-smokers and showed that the number reduced
exponentially after 3 years. This was substantiated more
recently by serial bronchoalveolar lavage measurements in
a never smoker who had a lung transplant from a smoking
donor.10 MSI remained at high levels at one year but was
reduced to 78%, 59% and 3% after 18 months, 2 years and 3
years respectively. We believe that the semi-quantitative
measurement of the number of macrophages containing
smokers inclusions may give information about current and
recent cigarette smoke exposure. All current smokers in the
present study were positive for MSI (Table 3) and 74% (95%
confidence interval 58.6e89.4%) showed either moderate
or many MSI. In contrast, 83% (95% confidence interval
74.8e91.2%) of ex-smokers showed no MSI and those with
moderate or many MSI had quit on average less than three
Table 2 Total and differential cell counts in induced
sputum.
Measurement Normal Non-smoker Ex-smoker Current
smoker
TCC, 106/g <9.7 6.4 (15.5) 10.2 (11.4) 6.9 (10.3)
Neutrophils,
%
<64.4 55.1 (24.1) 56.8 (23.5) 48.2 (21.7)
Eosinophils,
%
<2.0 1.7 (4.8) 2.6 (7.9) 0.8 (1.7)
Macrophages,
%
<86.1 41.9 (23.6) 39.8 (23.1) 50.5 (22.2)
Lymphocytes,
%
<2.6 0.6 (0.9) 0.5 (1.0) 0.2 (0.3)
TCC is total cell count. Data are expressed as mean (SD).
Normal values from Belda et al.29
Table 3 The relationship between macrophage smokers
inclusions (MSI) and cigarette smoking history.
MSI Non-smoker Ex-smoker Current smoker Total
None 141 67 0 208
Few 1 6 8 15
Moderate 0 5 10 15
Many 1 3 13 17
Total 143 81 31 255
Assessment of MSI was not possible in 1 current smoker.
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between the duration of cigarette smoke exposure and
semi-quantitative number of MSI in current smokers. Two
non-smokers also had positive MSI which were many in one
and few in the other. The former slide was re-reviewed:
many MSI were seen and the slide appeared to be labeled
correctly. The subject was seen subsequently the absence
of a history of either cigarette smoking or second hand
smoker exposure was confirmed. We do not have an
explanation why this non-smoking subject showed many MSI
in the sputum. In the non-smoking patient with few MSI we
could not exclude the possibility of second hand smoke
exposure.
We considered the cause for a raised lipid index in
smokers. It is unlikely to be due to exogenous inhaled lipid
from the tobacco, although lipid pneumonia has been
described in smokers of tobacco which has been moistened
with mineral oil (Black-fat tobacco).17 Corrin et al.18 haveFigure 2 Means (SEM) of lipid index (Units, 0e400) for
current smokers, ex-smokers and non-smokers. ) denotes
a significant (p < 0.05) difference between the lipid index of
current smokers and ex- or non-smokers.reported evidence of cholesterol in the cytoplasm of type II
pneumocytes of heavy tobacco smokers and have suggested
that this might be due to disorders of surfactant metabo-
lism. Indeed, in the acutely inflamed lung there are
increased levels of surfactant production, which is cleared
by macrophages and neutrophils.19 However, other authors
have shown the production of surfactant is reduced as
a result of tobacco smoke20 and its composition is
altered.21,22 Inclusions in macrophages in smokers have also
been reported to contain aluminum, silica and
kaolinite.23,24 These non-lipid inclusions may take up the
Wright’s stain. However they may also contain lipid, and
therefore be counted as part of the lipid index. This may
explain the close association between lipid index and MSI.
Regardless whether smoking causes a raised lipid index
directly, or indirectly by increasing MSI, the lipid index
should be used with caution to diagnose gastric aspiration
in patients who smoke.
This was a retrospective observational study and there-
fore accurate characterization of subjects was not possible.
In this respect we do not have objective evidence diag-
nosing or excluding gastroesophageal reflux, which may
result in confounding bias as smoking may result in
increased reflux, which in turn will produce a higher lipid
index. Indeed, patients who smoke have greater evidenceFigure 3 Mean (SEM) cigarette smoking history (pack years)
in current smokers with none, few, moderate or many MSI.
Sputum lipid and smoker’s inclusions 1695of reflux on 24 h pH monitoring25 due a reduction in lower
esophageal sphincter tone,26 an increase in the threshold
required for upper esophageal sphincter contraction,27 and
the associated coughing increases intra-abdominal pres-
sure.28 In a subgroup analysis of our smokers who had 24 h
pH monitoring, 11 out of 18 had evidence of gastroesoph-
ageal reflux, and there was no significant difference
between the lipid index of smokers with or without
gastroesophageal reflux. This suggests that smoking itself
causes an elevation in lipid index independently of gastro-
esophageal reflux however fuller analysis of this association
or the mechanisms are out of the scope of this paper.
In conclusion, we have shown that smoker’s inclusion
within sputum macrophages is a reliable indicator of ciga-
rette smoking. In patients who smoke, lipid index using Oil
Red O staining is not a reliable measure of gastric aspira-
tion. Furthermore, specimens which contain MSI, as iden-
tified by the Wrights stain, should not be used to evaluate
a lipid index using the Oil Red O stain. In these individuals
other investigations such as dual channel pH monitoring will
be more useful. Further studies are now required to eval-
uate whether other methods can be used to distinguish
between the lipid inclusions due to aspiration and those
due to tobacco smoking.
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